Completed PHASE3 INTERVENTIONAL 4-arm NCT00527800

Interactions Between HIV and Malaria in African Children (TCC)

Sponsor: Centers for Disease Control and Prevention

Interventions Artemether-lumefantrine Dihydroartemisinin-piperaquine Trimethoprim-sulfamethoxazole

Updated 6 times since 2017 Last updated: Oct 9, 2013 Started: Aug 31, 2007 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on HIV Infections and Malaria, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention and has accumulated 6 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
Makerere University
The AIDS Support Organization
University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tororo, Uganda